These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 18316385

  • 1. Murine model for assessment of Plasmodium falciparum transmission-blocking vaccine using transgenic Plasmodium berghei parasites expressing the target antigen Pfs25.
    Mlambo G, Maciel J, Kumar N.
    Infect Immun; 2008 May; 76(5):2018-24. PubMed ID: 18316385
    [Abstract] [Full Text] [Related]

  • 2. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
    Arakawa T, Komesu A, Otsuki H, Sattabongkot J, Udomsangpetch R, Matsumoto Y, Tsuji N, Wu Y, Torii M, Tsuboi T.
    Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536
    [Abstract] [Full Text] [Related]

  • 3. Functional immunogenicity of baculovirus expressing Pfs25, a human malaria transmission-blocking vaccine candidate antigen.
    Mlambo G, Kumar N, Yoshida S.
    Vaccine; 2010 Oct 08; 28(43):7025-9. PubMed ID: 20709008
    [Abstract] [Full Text] [Related]

  • 4. Induction of Plasmodium falciparum transmission-blocking antibodies in nonhuman primates by a combination of DNA and protein immunizations.
    Coban C, Philipp MT, Purcell JE, Keister DB, Okulate M, Martin DS, Kumar N.
    Infect Immun; 2004 Jan 08; 72(1):253-9. PubMed ID: 14688103
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of combination vaccines targeting transmission of Plasmodium falciparum and P. vivax.
    Cao Y, Hayashi CTH, Araujo MDS, Tripathi AK, Andrade AO, Medeiros JF, Vinetz J, Kumar N.
    Vaccine; 2024 Aug 30; 42(21):126140. PubMed ID: 39033079
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission.
    McGuire KA, Miura K, Wiethoff CM, Williamson KC.
    Malar J; 2017 Jun 15; 16(1):254. PubMed ID: 28619071
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25.
    Scally SW, McLeod B, Bosch A, Miura K, Liang Q, Carroll S, Reponen S, Nguyen N, Giladi E, Rämisch S, Yusibov V, Bradley A, Lemiale F, Schief WR, Emerling D, Kellam P, King CR, Julien JP.
    Nat Commun; 2017 Nov 16; 8(1):1568. PubMed ID: 29146922
    [Abstract] [Full Text] [Related]

  • 11. Functional characterization of Plasmodium berghei PSOP25 during ookinete development and as a malaria transmission-blocking vaccine candidate.
    Zheng W, Liu F, He Y, Liu Q, Humphreys GB, Tsuboi T, Fan Q, Luo E, Cao Y, Cui L.
    Parasit Vectors; 2017 Jan 05; 10(1):8. PubMed ID: 28057055
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anti-Pfs25 human plasma reduces transmission of Plasmodium falciparum isolates that have diverse genetic backgrounds.
    Da DF, Dixit S, Sattabonkot J, Mu J, Abate L, Ramineni B, Ouedraogo JB, MacDonald NJ, Fay MP, Su XZ, Cohuet A, Wu Y.
    Infect Immun; 2013 Jun 05; 81(6):1984-9. PubMed ID: 23509152
    [Abstract] [Full Text] [Related]

  • 16. Functional comparison of Plasmodium falciparum transmission-blocking vaccine candidates by the standard membrane-feeding assay.
    Miura K, Takashima E, Deng B, Tullo G, Diouf A, Moretz SE, Nikolaeva D, Diakite M, Fairhurst RM, Fay MP, Long CA, Tsuboi T.
    Infect Immun; 2013 Dec 05; 81(12):4377-82. PubMed ID: 24042109
    [Abstract] [Full Text] [Related]

  • 17. Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not mice.
    Healy SA, Anderson C, Swihart BJ, Mwakingwe A, Gabriel EE, Decederfelt H, Hobbs CV, Rausch KM, Zhu D, Muratova O, Herrera R, Scaria PV, MacDonald NJ, Lambert LE, Zaidi I, Coelho CH, Renn JP, Wu Y, Narum DL, Duffy PE.
    J Clin Invest; 2021 Apr 01; 131(7):. PubMed ID: 33561016
    [Abstract] [Full Text] [Related]

  • 18. Antibodies to plant-produced Plasmodium falciparum sexual stage protein Pfs25 exhibit transmission blocking activity.
    Farrance CE, Chichester JA, Musiychuk K, Shamloul M, Rhee A, Manceva SD, Jones RM, Mamedov T, Sharma S, Mett V, Streatfield SJ, Roeffen W, van de Vegte-Bolmer M, Sauerwein RW, Wu Y, Muratova O, Miller L, Duffy P, Sinden R, Yusibov V.
    Hum Vaccin; 2011 Apr 01; 7 Suppl():191-8. PubMed ID: 21266847
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Malaria Derived Glycosylphosphatidylinositol Anchor Enhances Anti-Pfs25 Functional Antibodies That Block Malaria Transmission.
    Kapoor N, Vanjak I, Rozzelle J, Berges A, Chan W, Yin G, Tran C, Sato AK, Steiner AR, Pham TP, Birkett AJ, Long CA, Fairman J, Miura K.
    Biochemistry; 2018 Feb 06; 57(5):516-519. PubMed ID: 29323879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.